Latest News

Q1 2026 Watch: HCV/HIV co-infection treatment access under evolving federal and state policies.

Q4 2025 Watch monitoring HCV treatment access and federal initiatives including Cure Hepatitis C Act.

Q3 2025 Watch: critical analysis including Cure Hepatitis C Act proposing subscription treatment models.

Q2 2025 Watch monitoring HCV and HIV treatment access through ADAPs, Medicaid, and federal assistance.

Bipartisan HCV elimination legislation analysis and critical legislative window.

Systemic barriers preventing HCV-infected people from accessing available cure.

Q2 2024 Watch: Prior authorization rollbacks in Medicaid HCV programs; ADAP and assistance program coverage.

Declining HCV infections but persistent treatment barriers and disparities remain.

Q1 2024 Watch: Pandemic Medicaid protections ended; millions lost coverage; ADAP and veterans updates.

Biden FY2024 budget includes $9.7B PrEP program and $11B Hepatitis Elimination Program.

WHO 2030 HCV elimination goal at risk; only 5 of 110 countries on track as COVID-19 disrupts progress.